I know a lot has been said about these abstracts. I jus thoughts I'd read through them and break down one of them (for my own benefit - and perhaps others)...Eureka + IMU...the below is taken from the abstracts...(except bolded titles).
Problem: HCC - second in the world!
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths in the world
Current treatment: Liver transplant, removal of tumor but even so a 5-year survival rate at less than 12%.
Current problems with solid tumours...
a. Tumor express many different targets (antigens).
b. Micro- enviroment (TME) suppresses Immune system.
Oncarlytics + T cell Eureka...
a. Puts a target on tumor. (solves problem a - above)
b. OV - reshapes the TME. (solves problem b above).
Conclusion...
"In summary, ARTEMIS® CD19 T cells combined with onCARlytics is a potentially effective immunotherapy strategy for the treatment of patients with HCC and can be applied to other solid tumors"
I know this is a. only pre-clinical and b. is there interest with BP? However the magnitude of this is just staggering, even if it only comes off at 20% of the potential.
DYOR and all that.
- Forums
- ASX - By Stock
- IMU
- Ann: onCARlytics to be showcased in three abstracts at SITC
Ann: onCARlytics to be showcased in three abstracts at SITC, page-81
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
6.0¢ |
Change
0.004(7.14%) |
Mkt cap ! $440.9M |
Open | High | Low | Value | Volume |
5.7¢ | 6.3¢ | 5.6¢ | $1.312M | 21.97M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 299223 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.1¢ | 450000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 296500 | 0.060 |
8 | 899945 | 0.059 |
10 | 1036582 | 0.058 |
11 | 2712529 | 0.057 |
13 | 718589 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.061 | 450000 | 3 |
0.062 | 615032 | 6 |
0.063 | 702930 | 9 |
0.064 | 564497 | 6 |
0.065 | 1433916 | 15 |
Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online